Laxmi Organic Industries’ Board has approved the unaudited standalone and consolidated financial results for the third quarter and nine months ending December 31, 2025. Additionally, the board approved the re-appointment of Dr. Rajiv Banavali as an Independent Director for a second term, subject to shareholder approval, effective from May 18, 2026, to May 17, 2028.
Financial Performance Q3 2026
Laxmi Organic Industries announced the approval of its unaudited financial results for Q3 2026. Both standalone and consolidated results were reviewed and approved by the Board.
Key Financial Details
The Board reviewed and approved the following:
- Approved Unaudited Standalone Financial Results for Q3 2026 and nine months ending December 31, 2025.
- Approved Unaudited Consolidated Financial Results for Q3 2026 and nine months ending December 31, 2025.
Detailed results are available on the company’s website and stock exchange platforms.
Director Re-Appointment
The Board also approved the re-appointment of Dr. Rajiv Banavali as an Independent Director.
Details of Re-Appointment
Based on the Nomination and Remuneration Committee’s recommendation, Dr. Rajiv Banavali was re-appointed as an Independent Director, not subject to retirement by rotation, for a second term of two years, from May 18, 2026, to May 17, 2028. This appointment is pending shareholder approval.
Additional Information
Dr. Banavali brings over 38 years of experience in the chemicals sector and has held leadership positions in research organizations.
Source: BSE
